Jason Zemansky Analyst PerformanceVice President at Bank of AmericaJason Zemansky is a stock analyst at Bank of America focused in the medical sector, covering 9 publicly traded companies. Over the past year, Jason Zemansky has issued 15 stock ratings, including buy and hold recommendations. While full access to Jason Zemansky's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jason Zemansky's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings18 Last 1 YearsBuy Recommendations61.11% 11 Buy RatingsCompanies Covered9 Unique Companies Ratings Distribution18RatingsDistribution of strong buy, buy, hold, and sell ratings by Jason Zemansky.RatingPercentageCount Strong Buy0.0%0 ratings Buy61.1%11 ratings Hold38.9%7 ratings Sell0.0%0 ratingsOut of 18 total stock ratings issued by Jason Zemansky at Bank of America, the majority (61.1%) have been Buy recommendations, followed by 38.9% Hold.Best & Worst CallsBest Call000.0%INSMMar 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ88.9% of companies on NASDAQ8 companiesNYSE11.1% of companies on NYSE1 companyJason Zemansky, an analyst at Bank of America, currently covers 9 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical7 companies77.8%Manufacturing2 companies22.2%Jason Zemansky of Bank of America specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE7 companies77.8%BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES2 companies22.2% Jason Zemansky's Ratings History at Bank of America Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsRCKTRocket Pharmaceuticals3/30/2026Boost Price Target$3.75$9.00Buy$0.0000.00% ROIINSMInsmed3/24/2026Boost Price Target$143.98$213.00Buy$0.0000.00% ROILGNDLigand Pharmaceuticals3/11/2026Initiated Coverage$212.29$244.00Buy$0.0000.00% ROIEIKNEIKN3/2/2026Initiated Coverage$13.78$34.00Buy$0.0000.00% ROICYTKCytokinetics2/25/2026Reiterated Rating$62.89Neutral$0.0000.00% ROIIKTInhibikase Therapeutics1/21/2026Initiated Coverage$1.65$6.00Buy$0.0000.00% ROIKROSKeros Therapeutics11/28/2025Boost Price Target$17.46$19.00Neutral$0.0000.00% ROIRCUSArcus Biosciences11/28/2025Boost Price Target$25.76$26.00Neutral$0.0000.00% ROIRCKTRocket Pharmaceuticals11/18/2025Lower Price Target$2.98$8.00Buy$0.0000.00% ROIHOWLWerewolf Therapeutics11/18/2025Lower Price Target$0.95$7.00Buy$0.0000.00% ROIINSMInsmed10/27/2025Boost Price Target$163.44$187.00Buy$0.0000.00% ROICYTKCytokinetics10/2/2025Boost Price Target$55.55$56.00Neutral$0.0000.00% ROIHOWLWerewolf Therapeutics8/25/2025Lower Price Target$1.37$8.00Buy$0.0000.00% ROIINSMInsmed6/11/2025Boost Price Target$90.93$109.00Buy$0.0000.00% ROIKROSKeros Therapeutics6/10/2025Downgrade$14.09$18.00Neutral$0.0000.00% ROICYTKCytokinetics4/15/2025Lower Price Target$38.63$54.00Neutral$00.0000.00% ROIINSMInsmed3/20/2025Boost Price Target$80.81$96.00Buy$000.0000.00% ROIRCUSArcus Biosciences2/19/2025Lower Price Target$11.00$17.00Neutral$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenMorgan StanleyRoyal Bank Of CanadaBerenberg BankUBS GroupCitigroupBarclaysWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTruist FinancialTD CowenPiper SandlerRaymond James Financial Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
